Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Vicarious Surgical Inc.RBOT · Entity 8714 | Director · President | February 20, 2026 | February 24, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Vicarious Surgical Inc.
Report date February 20, 2026 · Filed February 24, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 46,943 |
Reported balance
After 2026-02-20 transaction · row 1
1 source rowRow 1 · 2026-02-20 · Sale · Disposed 942 · Balance 46,943 F1: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on May 19, 2022. The sale is mandated by the Issuer's election under its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2: This figure is the weighted average sales price of multiple trades ranging from $1.845 to $2.290 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request. |
Filing footnotes · ownership attribution and instrument terms
F1: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on May 19, 2022. The sale is mandated by the Issuer's election under its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
F2: This figure is the weighted average sales price of multiple trades ranging from $1.845 to $2.290 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 20, 2026 Filed Feb 24, 2026 16:59 UTC | Vicarious Surgical Inc. RBOT · Entity 8714 | SaleClass A Common Stock | 942 | $2.09 | $1,966.71 |
DisclosureSEC source: 0001213900-26-019944 · ownership.xml · nonDerivative · entry 1 Sachs Adam David · CIK 0001885593 · Director · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,943 F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on May 19, 2022. The sale is mandated by the Issuer's election under its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · price: This figure is the weighted average sales price of multiple trades ranging from $1.845 to $2.290 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request. Read SEC document |
| December 03, 2025 Filed Dec 4, 2025 19:14 UTC | Vicarious Surgical Inc. RBOT · Entity 8714 | SaleClass A Common Stock | 463 | $2.95 | $1,366.78 |
DisclosureSEC source: 0001213900-25-118410 · ownership.xml · nonDerivative · entry 1 Sachs Adam David · CIK 0001885593 · Director · President · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,885 F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on June 2, 2023. The sale is mandated by the Issuer's election under its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · price: This figure is the weighted average sales price of multiple trades ranging from $2.715 to $3.34 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request. Read SEC document |
| November 20, 2025 Filed Nov 21, 2025 19:27 UTC | Vicarious Surgical Inc. RBOT · Entity 8714 | SaleClass A Common Stock | 816 | $2.72 | $2,215.44 |
DisclosureSEC source: 0001213900-25-113762 · ownership.xml · nonDerivative · entry 1 Sachs Adam David · CIK 0001885593 · Director · President · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,348 F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on May 19, 2022. The sale is mandated by the Issuer's election under its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · price: This figure is the weighted average sales price of multiple trades ranging from $2.54 to $2.94 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request. Read SEC document |
| September 03, 2025 Filed Sep 4, 2025 16:47 UTC | Vicarious Surgical Inc. RBOT · Entity 8714 | SaleClass A Common Stock | 463 | $5.76 | $2,665.21 |
DisclosureSEC source: 0001213900-25-084550 · ownership.xml · nonDerivative · entry 1 Sachs Adam David · CIK 0001885593 · Director · President · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,164 F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on June 2, 2023. The sale is mandated by the Issuer's election under its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · price: This figure is the weighted average sales price of multiple trades ranging from $5.64 to $5.87 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request. Read SEC document |
| August 20, 2025 Filed Aug 21, 2025 19:53 UTC | Vicarious Surgical Inc. RBOT · Entity 8714 | SaleClass A Common Stock | 817 | $6.03 | $4,927.49 |
DisclosureSEC source: 0001213900-25-079494 · ownership.xml · nonDerivative · entry 1 Sachs Adam David · CIK 0001885593 · Director · President · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,627 F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on May 19, 2022. The sale is mandated by the Issuer's election under its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · price: This figure is the weighted average sales price of multiple trades ranging from $5.90 to $6.32 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request. Read SEC document |
| June 27, 2025 Filed Aug 11, 2025 21:02 UTC | Vicarious Surgical Inc. RBOT · Entity 8714 | GrantStock Option (right to buy) · Derivative | 38,675 | $0.00 Strike: $7.61 | $0.00 |
DisclosureSEC source: 0001213900-25-074541 · ownership.xml · derivative · entry 1 Sachs Adam David · CIK 0001885593 · Director · President · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,675 Underlying: Class A Common Stock · 38,675 shares Expires 2035-06-26 F1 · derivative.exercise_date: The shares underlying this option vest in 48 equal monthly installments beginning on the one-month anniversary of the grant date, subject to the Reporting Person's continued service through the applicable vesting date. Read SEC document |
| June 23, 2025 Filed Jun 24, 2025 18:49 UTC | Vicarious Surgical Inc. RBOT · Entity 8714 | SaleClass A Common Stock | 279 | $7.80 | $2,176.09 |
DisclosureSEC source: 0001213900-25-057361 · ownership.xml · nonDerivative · entry 1 Sachs Adam David · CIK 0001885593 · Director · CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,444 F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on November 23, 2021. F2 · price: This figure is the weighted average sales price of multiple trades ranging from $7.62 to $7.90 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc.with full information about the number of shares sold at each separate price upon request. Read SEC document |
| June 03, 2025 Filed Jun 4, 2025 14:16 UTC | Vicarious Surgical Inc. RBOT · Entity 8714 | SaleClass A Common Stock | 463 | $7.22 | $3,342.54 |
DisclosureSEC source: 0001213900-25-051099 · ownership.xml · nonDerivative · entry 1 Sachs Adam David · CIK 0001885593 · Director · CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,723 F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on June 2, 2023. F2 · price: This figure is the weighted average sales price of multiple trades ranging from $7.01 to $7.52 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request. Read SEC document |
| May 20, 2025 Filed May 21, 2025 13:19 UTC | Vicarious Surgical Inc. RBOT · Entity 8714 | SaleClass A Common Stock | 817 | $7.53 | $6,150.13 |
DisclosureSEC source: 0001213900-25-046363 · ownership.xml · nonDerivative · entry 1 Sachs Adam David · CIK 0001885593 · Director · CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,186 F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on May 19, 2022. F2 · price: This figure is the weighted average sales price of multiple trades ranging from $7.275 to $7.86 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request. Read SEC document |
| March 21, 2025 Filed Mar 24, 2025 16:51 UTC | Vicarious Surgical Inc. RBOT · Entity 8714 | SaleClass A Common Stock | 161 | $7.92 | $1,275.06 |
DisclosureSEC source: 0001013762-25-001641 · ownership.xml · nonDerivative · entry 1 Sachs Adam David · CIK 0001885593 · Director · CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,003 F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on November 23, 2021. F2 · price: This figure is the weighted average sales price of multiple trades ranging from $7.73 to $8.09 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request. Read SEC document |
| March 03, 2025 Filed Mar 4, 2025 16:55 UTC | Vicarious Surgical Inc. RBOT · Entity 8714 | SaleClass A Common Stock | 535 | $10.28 | $5,499.32 |
DisclosureSEC source: 0001213900-25-020272 · ownership.xml · nonDerivative · entry 1 Sachs Adam David · CIK 0001885593 · Director · CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,164 F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on June 2, 2023. F2 · price: This figure is the weighted average sales price of multiple trades ranging from $9.40 to $11.00 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request. Read SEC document |
| February 20, 2025 Filed Feb 21, 2025 13:22 UTC | Vicarious Surgical Inc. RBOT · Entity 8714 | SaleClass A Common Stock | 943 | $14.53 | $13,704.81 |
DisclosureSEC source: 0001213900-25-016007 · ownership.xml · nonDerivative · entry 1 Sachs Adam David · CIK 0001885593 · Director · CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,699 F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on May 19, 2022. F2 · price: This figure is the weighted average sales price of multiple trades ranging from $14.08 to $15.50 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request. Read SEC document |
| December 23, 2024 Filed Dec 26, 2024 07:36 UTC | Vicarious Surgical Inc. RBOT · Entity 8714 | SaleClass A Common Stock | 139 | $12.27 | $1,705.27 |
DisclosureSEC source: 0001213900-24-112325 · ownership.xml · nonDerivative · entry 1 Sachs Adam David · CIK 0001885593 · Director · CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,642 F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on November 23, 2021. F2 · price: This figure is the weighted average sales price of multiple trades ranging from $11.6500 to $12.77 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request. Read SEC document |
| December 03, 2024 Filed Dec 4, 2024 15:01 UTC | Vicarious Surgical Inc. RBOT · Entity 8714 | SaleClass A Common Stock | 463 | $13.50 | $6,251.33 |
DisclosureSEC source: 0001213900-24-105581 · ownership.xml · nonDerivative · entry 1 Sachs Adam David · CIK 0001885593 · Director · CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,781 F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on June 2, 2023. F2 · price: This figure is the weighted average sales price of multiple trades ranging from $12.60 to $14.66 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request. Read SEC document |
| November 20, 2024 Filed Nov 21, 2024 14:14 UTC | Vicarious Surgical Inc. RBOT · Entity 8714 | SaleClass A Common Stock | 817 | $8.97 | $7,327.75 |
DisclosureSEC source: 0001213900-24-100911 · ownership.xml · nonDerivative · entry 1 Sachs Adam David · CIK 0001885593 · Director · CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,244 F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on May 19, 2022. F2 · price: This figure is the weighted average sales price of multiple trades ranging from $8.81 to 9.26 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request. Read SEC document |
| September 20, 2024 Filed Sep 23, 2024 16:07 UTC | Vicarious Surgical Inc. RBOT · Entity 8714 | SaleClass A Common Stock | 139 | $5.77 | $802.49 |
DisclosureSEC source: 0001213900-24-081027 · ownership.xml · nonDerivative · entry 1 Sachs Adam David · CIK 0001885593 · Director · CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,061 F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on November 23, 2021. F2 · price: This figure is the weighted average sales price of multiple trades ranging from $5.67 to $5.95 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request. Read SEC document |
| September 03, 2024 Filed Sep 5, 2024 17:15 UTC | Vicarious Surgical Inc. RBOT · Entity 8714 | SaleClass A Common Stock | 396 | $5.88 | $2,327.25 |
DisclosureSEC source: 0001213900-24-076177 · ownership.xml · nonDerivative · entry 1 Sachs Adam David · CIK 0001885593 · Director · CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,200 F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on June 2, 2021. F2 · price: This figure is the weighted average sales price of multiple trades ranging from $5.58 to $6.26 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request. Read SEC document |
| August 20, 2024 Filed Aug 21, 2024 13:23 UTC | Vicarious Surgical Inc. RBOT · Entity 8714 | SaleClass A Common Stock | 698 | $6.32 | $4,412.55 |
DisclosureSEC source: 0001213900-24-071369 · ownership.xml · nonDerivative · entry 1 Sachs Adam David · CIK 0001885593 · Director · CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,596 F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on May 19, 2022. F2 · price: This figure is the weighted average sales price of multiple trades ranging from $6.16 to $6.625 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request. Read SEC document |
| July 18, 2024 Filed Jul 22, 2024 14:38 UTC | Vicarious Surgical Inc. RBOT · Entity 8714 | SaleClass A Common Stock | 100 | $7.96 | $795.90 |
DisclosureSEC source: 0001013762-24-000392 · ownership.xml · nonDerivative · entry 1 Sachs Adam David · CIK 0001885593 · Director · CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,294 F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on November 23, 2021. F2 · price: This figure is the weighted average sales price of multiple trades ranging from $7.78 to $8.21 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request. F3 · balance_after: On June 13, 2024, the Issuer effected a 1-for-30 reverse stock split (the "Reverse Stock Split") on its Common Stock. The number of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split. Read SEC document |
| June 17, 2024 Filed Jun 18, 2024 17:15 UTC | Vicarious Surgical Inc. RBOT · Entity 8714 | GrantStock Option (right to buy) · Derivative | 12,946 | $0.00 Strike: $6.86 | $0.00 |
DisclosureSEC source: 0001213900-24-053878 · ownership.xml · derivative · entry 1 Sachs Adam David · CIK 0001885593 · Director · CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,946 Underlying: Class A Common Stock · 12,946 shares Expires 2034-06-16 F1 · derivative.exercise_date: The shares underlying this option vest in equal monthly installments over 48 months beginning on June 17, 2024, subject to Mr. Sachs' continued service through the applicable vesting date. Read SEC document |
| June 03, 2024 Filed Jun 4, 2024 15:23 UTC | Vicarious Surgical Inc. RBOT · Entity 8714 | SaleClass A Common Stock | 13,896 | $0.32 | $4,468.95 |
DisclosureSEC source: 0001213900-24-049597 · ownership.xml · nonDerivative · entry 1 Sachs Adam David · CIK 0001885593 · Director · CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,691,822 F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on June 2, 2023. F2 · price: This figure is the weighted average sales price of multiple trades ranging from $0.3099 to $0.3399 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request. Read SEC document |
| May 20, 2024 Filed May 21, 2024 13:43 UTC | Vicarious Surgical Inc. RBOT · Entity 8714 | SaleClass A Common Stock | 24,502 | $0.39 | $9,506.78 |
DisclosureSEC source: 0001213900-24-045511 · ownership.xml · nonDerivative · entry 1 Sachs Adam David · CIK 0001885593 · Director · CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,705,718 F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on May 19, 2022. F2 · price: This figure is the weighted average sales price of multiple trades ranging from $0.3799 to $0.3987 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request. Read SEC document |
| March 20, 2024 Filed Mar 21, 2024 15:53 UTC | Vicarious Surgical Inc. RBOT · Entity 8714 | SaleClass A Common Stock | 4,830 | $0.34 | $1,652.83 |
DisclosureSEC source: 0001213900-24-024752 · ownership.xml · nonDerivative · entry 1 Sachs Adam David · CIK 0001885593 · Director · CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,730,220 F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on November 23, 2021. F2 · price: This figure is the weighted average sales price of multiple trades ranging from $0.3329 to $0.3569 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request. Read SEC document |
| March 04, 2024 Filed Mar 5, 2024 16:33 UTC | Vicarious Surgical Inc. RBOT · Entity 8714 | SaleClass A Common Stock | 16,040 | $0.37 | $5,954.05 |
DisclosureSEC source: 0001213900-24-020150 · ownership.xml · nonDerivative · entry 1 Sachs Adam David · CIK 0001885593 · Director · CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,735,050 F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on June 2, 2023. F2 · price: This figure is the weighted average sales price of multiple trades ranging from $0.357 to $0.3889 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request. Read SEC document |
| February 20, 2024 Filed Feb 21, 2024 17:29 UTC | Vicarious Surgical Inc. RBOT · Entity 8714 | SaleClass A Common Stock | 28,282 | $0.36 | $10,093.85 |
DisclosureSEC source: 0001213900-24-015862 · ownership.xml · nonDerivative · entry 1 Sachs Adam David · CIK 0001885593 · Director · CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,751,090 F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on May 19, 2022. F2 · price: This figure is the weighted average sales price of multiple trades ranging from $0.35 to $0.3713 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request. Read SEC document |
| September 20, 2023 Filed Sep 22, 2023 16:21 UTC | Vicarious Surgical Inc. RBOT · Entity 8714 | SaleClass A Common Stock | 4,142 | $0.79 | $3,260.58 |
DisclosureSEC source: 0001213900-23-078775 · ownership.xml · nonDerivative · entry 1 Sachs Adam David · CIK 0001885593 · Director · President and CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,779,372 F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on November 23, 2021. F2 · price: This figure is the weighted average sales price of multiple trades ranging from $0.7731 to $0.7998 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request. Read SEC document |
| September 05, 2023 Filed Sep 7, 2023 17:39 UTC | Vicarious Surgical Inc. RBOT · Entity 8714 | SaleClass A Common Stock | 13,754 | $0.97 | $13,377.14 |
DisclosureSEC source: 0001213900-23-075089 · ownership.xml · nonDerivative · entry 1 Sachs Adam David · CIK 0001885593 · Director · President and CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,783,514 F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on June 2, 2023. F2 · price: This figure is the weighted average sales price of multiple trades ranging from $0.9475 to $1.005 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request. Read SEC document |
| August 21, 2023 Filed Aug 22, 2023 12:47 UTC | Vicarious Surgical Inc. RBOT · Entity 8714 | SaleClass A Common Stock | 24,251 | $0.91 | $22,051.43 |
DisclosureSEC source: 0001213900-23-069797 · ownership.xml · nonDerivative · entry 1 Sachs Adam David · CIK 0001885593 · Director · President and CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,797,268 F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on May 19, 2022. F2 · price: This figure is the weighted average sales price of multiple trades ranging from $0.887 to $0.9346 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request. Read SEC document |
| June 20, 2023 Filed Jun 22, 2023 16:44 UTC | Vicarious Surgical Inc. RBOT · Entity 8714 | SaleClass A Common Stock | 4,142 | $2.05 | $8,491.10 |
DisclosureSEC source: 0001213900-23-051006 · ownership.xml · nonDerivative · entry 1 Sachs Adam David · CIK 0001885593 · Director · President and CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,821,519 F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on November 23, 2021. F2 · price: This figure is the weighted average sales price of multiple trades ranging from $2.03 to $2.06 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request. Read SEC document |
| June 02, 2023 Filed Jun 6, 2023 15:25 UTC | Vicarious Surgical Inc. RBOT · Entity 8714 | GrantClass A Common Stock | 647,266 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-23-046726 · ownership.xml · nonDerivative · entry 1 Sachs Adam David · CIK 0001885593 · Director · President and CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,825,661 F1 · kind: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Class A common stock upon vesting. The RSUs vest in 16 equal quarterly installments over the four years following the date of grant, subject to the Reporting Person's continued service to Vicarious Surgical Inc. through the applicable vesting date. Read SEC document |
| May 22, 2023 Filed May 24, 2023 15:25 UTC | Vicarious Surgical Inc. RBOT · Entity 8714 | SaleClass A Common Stock | 24,252 | $2.24 | $54,365.71 |
DisclosureSEC source: 0001213900-23-042679 · ownership.xml · nonDerivative · entry 1 Sachs Adam David · CIK 0001885593 · Director · President and CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,178,395 F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on May 19, 2022. F2 · price: This figure is the weighted average sales price of multiple trades ranging from $2.090 to $2.350 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request. Read SEC document |
| March 22, 2023 Filed Mar 23, 2023 17:44 UTC | Vicarious Surgical Inc. RBOT · Entity 8714 | SaleClass A Common Stock | 4,263 | $2.45 | $10,448.61 |
DisclosureSEC source: 0001213900-23-022509 · ownership.xml · nonDerivative · entry 1 Sachs Adam David · CIK 0001885593 · Director · President and CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,202,647 F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on November 23, 2021. F2 · price: This figure is the weighted average sales price of multiple trades ranging from $2.451 to $2.456 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request. Read SEC document |
| February 21, 2023 Filed Feb 22, 2023 18:39 UTC | Vicarious Surgical Inc. RBOT · Entity 8714 | SaleClass A Common Stock | 23,538 | $2.78 | $65,381.50 |
DisclosureSEC source: 0001213900-23-013744 · ownership.xml · nonDerivative · entry 1 Sachs Adam David · CIK 0001885593 · Director · President and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,206,910 F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on May 19, 2022. F2 · price: This figure is the weighted average sales price of multiple trades ranging from $2.73 to $2.82 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request. Read SEC document |
| December 20, 2022 Filed Dec 22, 2022 15:54 UTC | Vicarious Surgical Inc. RBOT · Entity 8714 | SaleClass A Common Stock | 4,019 | $1.84 | $7,410.63 |
DisclosureSEC source: 0001213900-22-082166 · ownership.xml · nonDerivative · entry 1 Sachs Adam David · CIK 0001885593 · Director · President and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,230,448 F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on November 23, 2021. F2 · price: This figure is the weighted average sales price of multiple trades ranging from $1.795 to $1.91 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request. Read SEC document |
| November 28, 2022 Filed Nov 30, 2022 12:34 UTC | Vicarious Surgical Inc. RBOT · Entity 8714 | SaleClass A Common Stock | 8,325 | $3.45 | $28,721.25 |
DisclosureSEC source: 0001213900-22-076205 · ownership.xml · nonDerivative · entry 3 Sachs Adam David · CIK 0001885593 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,234,467 F4 · kind: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 15, 2022. F5 · price: This figure is the weighted average sales price of multiple trades ranging from $3.36 to $3.62 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request. Read SEC document |
| November 28, 2022 Filed Nov 30, 2022 12:34 UTC | Vicarious Surgical Inc. RBOT · Entity 8714 | SaleClass A Common Stock | 11,329 | $3.43 | $38,858.47 |
DisclosureSEC source: 0001213900-22-076205 · ownership.xml · nonDerivative · entry 2 Sachs Adam David · CIK 0001885593 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,242,792 F2 · kind: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 15, 2022. F3 · price: This figure is the weighted average sales price of multiple trades ranging from $3.37 to $3.48 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request. Read SEC document |
| November 28, 2022 Filed Nov 30, 2022 12:34 UTC | Vicarious Surgical Inc. RBOT · Entity 8714 | ConversionClass A Common Stock | 11,329 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001213900-22-076205 · ownership.xml · nonDerivative · entry 1 Sachs Adam David · CIK 0001885593 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,254,121 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of Class B Common Stock, par value $0.0001 per share (the "Class B Common Stock"), was converted into one share of Class A Common Stock, par value $0.0001 per share (the "Class A Common Stock"), for no additional consideration at the option of the Reporting Person. The shares of Class B Common Stock are convertible into an equal number of shares of Class A Common Stock at the Reporting Person's election and have no expiration date. Read SEC document |
| November 28, 2022 Filed Nov 30, 2022 18:51 UTC Amendment | Vicarious Surgical Inc. RBOT · Entity 8714 | ConversionClass B Common Stock · Derivative | 11,329 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-22-076481 · ownership.xml · derivative · entry 1 Sachs Adam David · CIK 0001885593 · Director · President and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,239,063 Underlying: Class A Common Stock · 11,329 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Class B Common Stock, par value $0.0001 per share (the "Class B Common Stock"), was converted into one share of Class A Common Stock, par value $0.0001 per share (the "Class A Common Stock"), for no additional consideration at the option of the Reporting Person. The shares of Class B Common Stock are convertible into an equal number of shares of Class A Common Stock at the Reporting Person's election and have no expiration date. F2 · date: On November 30, 2022, the reporting person filed a Form 4 that mistakenly indicated an incorrect transaction date for the conversion of Class B Common Stock. The correct transaction date is 11/28/2022. F1 · derivative.exercise_date: Each share of Class B Common Stock, par value $0.0001 per share (the "Class B Common Stock"), was converted into one share of Class A Common Stock, par value $0.0001 per share (the "Class A Common Stock"), for no additional consideration at the option of the Reporting Person. The shares of Class B Common Stock are convertible into an equal number of shares of Class A Common Stock at the Reporting Person's election and have no expiration date. F1 · derivative.expiration_date: Each share of Class B Common Stock, par value $0.0001 per share (the "Class B Common Stock"), was converted into one share of Class A Common Stock, par value $0.0001 per share (the "Class A Common Stock"), for no additional consideration at the option of the Reporting Person. The shares of Class B Common Stock are convertible into an equal number of shares of Class A Common Stock at the Reporting Person's election and have no expiration date. Read SEC document |
| November 21, 2022 Filed Nov 22, 2022 17:48 UTC | Vicarious Surgical Inc. RBOT · Entity 8714 | SaleClass A Common Stock | 22,886 | $3.25 | $74,471.04 |
DisclosureSEC source: 0001213900-22-074649 · ownership.xml · nonDerivative · entry 1 Sachs Adam David · CIK 0001885593 · Director · President and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,242,792 F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on May 19, 2022. F2 · price: This figure is the weighted average sales price of multiple trades ranging from $3.185 to $3.335 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request. Read SEC document |
| October 27, 2022 Filed Oct 28, 2022 15:18 UTC | Vicarious Surgical Inc. RBOT · Entity 8714 | ConversionClass B Common Stock · Derivative | 11,329 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-22-067118 · ownership.xml · derivative · entry 3 Sachs Adam David · CIK 0001885593 · Director · President and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,250,392 Underlying: Class A Common Stock · 11,329 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Class B Common Stock, par value $0.0001 per share (the "Class B Common Stock"), was converted into one share of Class A Common Stock, par value $0.0001 per share (the "Class A Common Stock"), for no additional consideration at the option of the Reporting Person. The shares of Class B Common Stock are convertible into an equal number of shares of Class A Common Stock at the Reporting Person's election and have no expiration date. F1 · derivative.exercise_date: Each share of Class B Common Stock, par value $0.0001 per share (the "Class B Common Stock"), was converted into one share of Class A Common Stock, par value $0.0001 per share (the "Class A Common Stock"), for no additional consideration at the option of the Reporting Person. The shares of Class B Common Stock are convertible into an equal number of shares of Class A Common Stock at the Reporting Person's election and have no expiration date. F1 · derivative.expiration_date: Each share of Class B Common Stock, par value $0.0001 per share (the "Class B Common Stock"), was converted into one share of Class A Common Stock, par value $0.0001 per share (the "Class A Common Stock"), for no additional consideration at the option of the Reporting Person. The shares of Class B Common Stock are convertible into an equal number of shares of Class A Common Stock at the Reporting Person's election and have no expiration date. Read SEC document |
| October 27, 2022 Filed Oct 28, 2022 15:18 UTC | Vicarious Surgical Inc. RBOT · Entity 8714 | SaleClass A Common Stock | 11,329 | $3.43 | $38,847.14 |
DisclosureSEC source: 0001213900-22-067118 · ownership.xml · nonDerivative · entry 2 Sachs Adam David · CIK 0001885593 · Director · President and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,265,678 F2 · kind: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 15, 2022. F3 · price: This figure is the weighted average sales price of multiple trades ranging from $3.34 to $3.53 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request. Read SEC document |
| October 27, 2022 Filed Oct 28, 2022 15:18 UTC | Vicarious Surgical Inc. RBOT · Entity 8714 | ConversionClass A Common Stock | 11,329 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001213900-22-067118 · ownership.xml · nonDerivative · entry 1 Sachs Adam David · CIK 0001885593 · Director · President and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,277,007 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of Class B Common Stock, par value $0.0001 per share (the "Class B Common Stock"), was converted into one share of Class A Common Stock, par value $0.0001 per share (the "Class A Common Stock"), for no additional consideration at the option of the Reporting Person. The shares of Class B Common Stock are convertible into an equal number of shares of Class A Common Stock at the Reporting Person's election and have no expiration date. Read SEC document |
| September 28, 2022 Filed Sep 29, 2022 15:42 UTC | Vicarious Surgical Inc. RBOT · Entity 8714 | SaleClass A Common Stock | 8,497 | $3.48 | $29,569.56 |
DisclosureSEC source: 0001213900-22-060161 · ownership.xml · nonDerivative · entry 3 Sachs Adam David · CIK 0001885593 · Director · President and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,265,678 F4 · kind: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2021. F5 · price: This figure is the weighted average sales price of multiple trades ranging from $3.33 to $3.52 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request. Read SEC document |
| September 27, 2022 Filed Sep 29, 2022 15:42 UTC | Vicarious Surgical Inc. RBOT · Entity 8714 | ConversionClass B Common Stock · Derivative | 11,329 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-22-060161 · ownership.xml · derivative · entry 4 Sachs Adam David · CIK 0001885593 · Director · President and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,261,721 Underlying: Class A Common Stock · 11,329 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Class B Common Stock, par value $0.0001 per share (the "Class B Common Stock"), was converted into one share of Class A Common Stock, par value $0.0001 per share (the "Class A Common Stock"), for no additional consideration at the option of the Reporting Person. The shares of Class B Common Stock are convertible into an equal number of shares of Class A Common Stock at the Reporting Person's election and have no expiration date. F1 · derivative.exercise_date: Each share of Class B Common Stock, par value $0.0001 per share (the "Class B Common Stock"), was converted into one share of Class A Common Stock, par value $0.0001 per share (the "Class A Common Stock"), for no additional consideration at the option of the Reporting Person. The shares of Class B Common Stock are convertible into an equal number of shares of Class A Common Stock at the Reporting Person's election and have no expiration date. F1 · derivative.expiration_date: Each share of Class B Common Stock, par value $0.0001 per share (the "Class B Common Stock"), was converted into one share of Class A Common Stock, par value $0.0001 per share (the "Class A Common Stock"), for no additional consideration at the option of the Reporting Person. The shares of Class B Common Stock are convertible into an equal number of shares of Class A Common Stock at the Reporting Person's election and have no expiration date. Read SEC document |
| September 27, 2022 Filed Sep 29, 2022 15:42 UTC | Vicarious Surgical Inc. RBOT · Entity 8714 | SaleClass A Common Stock | 11,329 | $3.41 | $38,631.89 |
DisclosureSEC source: 0001213900-22-060161 · ownership.xml · nonDerivative · entry 2 Sachs Adam David · CIK 0001885593 · Director · President and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,274,175 F2 · kind: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 15, 2022. F3 · price: This figure is the weighted average sales price of multiple trades ranging from $3.34 to $3.50 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request. Read SEC document |
| September 27, 2022 Filed Sep 29, 2022 15:42 UTC | Vicarious Surgical Inc. RBOT · Entity 8714 | ConversionClass A Common Stock | 11,329 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001213900-22-060161 · ownership.xml · nonDerivative · entry 1 Sachs Adam David · CIK 0001885593 · Director · President and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,285,504 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of Class B Common Stock, par value $0.0001 per share (the "Class B Common Stock"), was converted into one share of Class A Common Stock, par value $0.0001 per share (the "Class A Common Stock"), for no additional consideration at the option of the Reporting Person. The shares of Class B Common Stock are convertible into an equal number of shares of Class A Common Stock at the Reporting Person's election and have no expiration date. Read SEC document |
| September 27, 2022 Filed Nov 30, 2022 12:34 UTC | Vicarious Surgical Inc. RBOT · Entity 8714 | ConversionClass B Common Stock · Derivative | 11,329 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-22-076205 · ownership.xml · derivative · entry 4 Sachs Adam David · CIK 0001885593 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,239,063 Underlying: Class A Common Stock · 11,329 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Class B Common Stock, par value $0.0001 per share (the "Class B Common Stock"), was converted into one share of Class A Common Stock, par value $0.0001 per share (the "Class A Common Stock"), for no additional consideration at the option of the Reporting Person. The shares of Class B Common Stock are convertible into an equal number of shares of Class A Common Stock at the Reporting Person's election and have no expiration date. F1 · derivative.exercise_date: Each share of Class B Common Stock, par value $0.0001 per share (the "Class B Common Stock"), was converted into one share of Class A Common Stock, par value $0.0001 per share (the "Class A Common Stock"), for no additional consideration at the option of the Reporting Person. The shares of Class B Common Stock are convertible into an equal number of shares of Class A Common Stock at the Reporting Person's election and have no expiration date. F1 · derivative.expiration_date: Each share of Class B Common Stock, par value $0.0001 per share (the "Class B Common Stock"), was converted into one share of Class A Common Stock, par value $0.0001 per share (the "Class A Common Stock"), for no additional consideration at the option of the Reporting Person. The shares of Class B Common Stock are convertible into an equal number of shares of Class A Common Stock at the Reporting Person's election and have no expiration date. Read SEC document |
| September 21, 2022 Filed Sep 22, 2022 19:18 UTC | Vicarious Surgical Inc. RBOT · Entity 8714 | SaleClass A Common Stock | 3,683 | $3.89 | $14,326.87 |
DisclosureSEC source: 0001213900-22-058106 · ownership.xml · nonDerivative · entry 1 Sachs Adam David · CIK 0001885593 · Director · President and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,274,175 F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on November 23, 2021. F2 · price: This figure is the weighted average sales price of multiple trades ranging from $3.80 to $4.00 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request. F3 · balance_after: Reflects a correction to the amount of shares beneficially held, which amount as provided in the Form 4s filed on August 29, 2022 and September 7, 2022 reflected an error. Read SEC document |
| September 02, 2022 Filed Sep 7, 2022 19:09 UTC | Vicarious Surgical Inc. RBOT · Entity 8714 | SaleClass A Common Stock | 492 | $3.75 | $1,843.52 |
DisclosureSEC source: 0001213900-22-054625 · ownership.xml · nonDerivative · entry 1 Sachs Adam David · CIK 0001885593 · Director · President and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,277,867 F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on May 19, 2022. F2 · price: This figure is the weighted average sales price of multiple trades ranging from $3.665 to $3.82 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request. Read SEC document |
| September 01, 2022 Filed Sep 2, 2022 16:47 UTC | Vicarious Surgical Inc. RBOT · Entity 8714 | SaleClass A Common Stock | 1,646 | $3.70 | $6,083.62 |
DisclosureSEC source: 0001213900-22-053908 · ownership.xml · nonDerivative · entry 2 Sachs Adam David · CIK 0001885593 · Director · President and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,278,359 F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on May 19, 2022. F3 · price: This figure is the weighted average sales price of multiple trades ranging from $3.59 to $3.82 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.